Medical Microbiology and Immunology

Papers
(The TQCC of Medical Microbiology and Immunology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Production of recombinant electron transfer flavoprotein beta subunit protein and its application in a lateral flow assay for early diagnosis of leptospirosis103
Cytolethal distending toxin-producing Escherichia coli clinical isolates from Mexican children harbor different cdt types causing CDT-induced epithelial pathological phenotypes100
Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants63
In vitro and in vivo therapeutic antileishmanial potential of ellagic acid against Leishmania donovani in murine model48
Immune complexes as culprits of immunopathology in severe COVID-1944
Gene biomarkers and classifiers for various subtypes of HTLV-1-caused ATLL cancer identified by a combination of differential gene co‑expression and support vector machine algorithms39
A high CMV-specific T cell response associates with SARS-CoV-2-specific IL-17 T cell production27
Repurposing promethazine hydrochloride to inhibit biofilm formation against Burkholderia thailandensis27
Cytokine responses of immunosuppressed and immunocompetent patients with Neoehrlichia mikurensis infection24
Picking up speed: cell cycle regulation during effector CD8+ T cell differentiation23
Understanding host–pathogen interaction: paving the path for individualized anti-infective therapy21
Proportions of IgA antibodies targeting glycosylated epitopes of secreted Escherichia coli mucinase YghJ in initial plasmablast response differ from salivary and intestinally secreted IgA19
Significance of diagnostic and therapeutic potential of serum endothelial and inflammatory biomarkers in defining disease severity of dengue infected patients19
Serotype distribution, antibiotic resistance, multilocus sequence typing, and virulence factors of invasive and non-invasive Streptococcus pneumoniae in Northeast China from 2000 to 202117
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants17
Long non-coding RNA NEAT1 promotes lipopolysaccharide-induced injury in human tubule epithelial cells by regulating miR-93-5p/TXNIP axis16
Human cytomegalovirus multiple-strain infections and viral population diversity in haematopoietic stem cell transplant recipients analysed by high-throughput sequencing15
Contributing role of TNF, IL-10, sTNFR1 and TNF gene polymorphisms in disease severity of leptospirosis15
Editorial on special issue on “Immunobiology of Viral Infections”13
Dissemination of arr-2 and arr-3 is associated with class 1 integrons in Klebsiella pneumoniae clinical isolates from Portugal12
Eicosapentaenoic acid influences the pathogenesis of Candida albicans in Caenorhabditis elegans via inhibition of hyphal formation and stimulation of the host immune response12
Reduced neutralization against Delta, Gamma, Mu, and Omicron BA.1 variants of SARS-CoV-2 from previous non-Omicron infection12
Cellular metabolic basis of altered immunity in the lungs of patients with COVID-1911
Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients11
Stability of cytokine, cellular and clinical response to the intravenous LPS challenge repeated after one year: a healthy volunteer trial11
Inflammatory cytokine profile and T cell responses in African tick bite fever patients11
Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy11
Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality10
Cytomegalovirus immune evasion sets the functional avidity threshold for protection by CD8 T cells9
IgG antibody response to pneumococcal-conjugated vaccine (Prevenar®13) in children with immunodeficiency disorders9
SARS-CoV-2 herd immunity of the Kyrgyz population in 20219
0.051730871200562